Clinical Trial Update: Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating adalimumab for uveitis in juvenile idiopathic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis
• Uveitis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Uveitis, Juvenile Arthritis | Phase 2, Phase 3 | Status: COMPLETED